Peter F. Lebowitz
Medical Oncology Clinical Research Unit
National Cancer Institute/NIH
9000 Rockville Pike
Bethesda
USA
Name/email consistency: high
- A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer. Lebowitz, P.F., Eng-Wong, J., Widemann, B.C., Balis, F.M., Jayaprakash, N., Chow, C., Clark, G., Gantz, S.B., Venzon, D., Zujewski, J. Clin. Cancer Res. (2005)